CSI Market
Sign In | Register

Corcept Therapeutics Inc (CORT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CORT Annual Balance Sheets →
The data below summarizes Corcept Therapeutics Inc's balance sheet position from Jun 30 2025 to Jun 30 2026, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent111.04
Marketable Securities, Current SH197.16
Cash & Short-term Investments308.00
Accounts receivable76.92
Notes Receivable, Current4.50
Inventories13.19
Other Current Assets0.00
Prepaid Expense And Other Assets Current17.57
Total Current Assets439.68
Equipment/Property/Plant Net5.13
Long-term investments236.45
Other Assets, Noncurrent207.44
Operating Lease Right Of Use Asset7.20
Deferred Income Tax Assets Net181.56
Total Assets888.70
Liabilities
Accounts Payable, Current AC14.91
Accrued Liabilities, Current AC115.35
Other Liabilities, Current23.55
Total Current Liabilities153.80
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent AC115.49
Other liabilities, Noncurrent13.64
Accrued Clinical Expenses Current34.09
Operating Lease Liability Current1.63
Operating Lease Liability Noncurrent8.01
Total Liabilities182.93
Stockholders' Equity
Treasury Stock Common Value-976.69
Common Stock Value0.14
Additional Paid In Capital Common Stock1,048.60
Retained Earnings / Accumulated Deficit654.61
Accumulated Other Comprehensive Income0.44
Other Equity0.44
Common Stockholder's Equity705.78
Total Stockholder's Equity705.78
Liabilities & Stockholder's Equity888.70
4 historic quarters locked

Sign in to unlock the full Corcept Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Corcept Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-050613

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.